76Bio

New York, United States

76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.

$10.0M raised

Jan 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has 76Bio raised?

76Bio has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.

Who are 76Bio's investors?

76Bio's investors include Polaris Partners.

Where is 76Bio headquartered?

76Bio is headquartered in New York, United States.

What does 76Bio do?

76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.

What stage is 76Bio at?

76Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2022.

MLA

"76Bio — Funding & Investors." VCBacked, January 7, 2022, https://www.vcbacked.co/company/76bio. Accessed July 4, 2026.

APA

VCBacked. (2022). 76Bio — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/76bio

Wikipedia (cite web)

{{cite web |title=76Bio — Funding & Investors |url=https://www.vcbacked.co/company/76bio |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2022.